“Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-positive patients”, Can Dermatol Today, vol. 4, no. 3, pp. 5–10, Sep. 2023, Accessed: Mar. 19, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/4-3-fournier